emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Funding round led by LFPI, Idia Capital Invest and Unigrains / Bioline Group (Invivo Agrosciences)

No EMAT : 103213
Announced Date : 04/04/2018
Type : Acquisition of Minority Stake
Deal Value : Yes
Acquirer : Funding round led by LFPI, Idia Capital Invest and Unigrains

Target : Bioline Group (Invivo Agrosciences)
Country : Paris
Sector of activity :
  • Health, Pharmaceuticals & Biotechnology > Biotechnology
  • Fertilizers & Pesticides > Specialty Chemicals > Chemicals > Fertilizers & Pesticides - Manufacturers
Business Description :
Founded in 2016, Bioline Group produces and markets a wide range of invertebrate biological control organisms which are used for control of insect pests in a variety of crops . > Primary target...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current ns ns
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Biotechnology » = 42
  • Number of EMAT Reports / sub-sector « Fertilizers & Pesticides - Manufacturers » = 38
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
06/07/2018 Olmix Amendis Côtes-D'Armor * 103170
19/06/2018 Olmix Micromix Plant Health (MPH) United Kingdom *** 103158

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report